Anaemia and renal dysfunction are independently associated with BNP and NT-proBNP levels in patients with heart failure

European Journal of Heart Failure

Volumn 9, Issue 8, 2007, Pages 787-794

  Hogenhuis, Jochem ^a   Voors, Adriaan A ^a   Jaarsma, Tiny ^a   Hoes, Arno W ^b   Hillege, Hans L ^a   Kragten, Johannes A ^c   van Veldhuisen, Dirk J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c Sittard Geleen Heerlen   (Netherlands)

Author keywords

Anaemia; BNP; Heart failure; NT proBNP; Renal dysfunction

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HEMOGLOBIN;

ADULT; AGED; ANEMIA; ARTICLE; CARDIOVASCULAR DISEASE; COMORBIDITY; DISEASE ASSOCIATION; FEMALE; GLOMERULUS FILTRATION RATE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEMOGLOBIN DETERMINATION; HOSPITAL PATIENT; HUMAN; KIDNEY DISEASE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; UNIVARIATE ANALYSIS;

AGED; ANEMIA; CREATININE; FEMALE; GLOMERULAR FILTRATION RATE; HEART FAILURE; HUMANS; KIDNEY DISEASES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS;

EID: 34547698954     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2007.04.001     Document Type: Article

References (30)

1. Maisel A.S., Krishnaswamy P., Nowak R.M., et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 347 (2002) 161-167
2. Januzzi J.L., van K.R., Lainchbury J., Bayes-Genis A., et al. NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study. Eur Heart J 27 (2006) 330-337
3. Mukoyama M., Nakao K., Saito Y., et al. Increased human brain natriuretic peptide in congestive heart failure. N Engl J Med 323 (1990) 757-758
4. Anwaruddin S., Lloyd-Jones D.M., Baggish A., et al. Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study. J Am Coll Cardiol 47 (2006) 91-99
5. Chenevier-Gobeaux C., Claessens Y.E., Voyer S., Desmoulins D., and Ekindjian O.G. Influence of renal function on N-terminal pro-brain natriuretic peptide (NT-proBNP) in patients admitted for dyspnoea in the Emergency Department: comparison with brain natriuretic peptide (BNP). Clin Chim Acta 361 (2005) 167-175
6. Das S.R., Drazner M.H., Dries D.L., et al. Impact of body mass and body composition on circulating levels of natriuretic peptides: results from the Dallas Heart Study. Circulation 112 (2005) 2163-2168
7. Hogenhuis J., Voors A.A., Jaarsma T., Hillege H.L., Boomsma F., and van Veldhuisen D.J. Influence of age on natriuretic peptides in patients with chronic heart failure: a comparison between ANP/NT-ANP and BNP/NT-proBNP. Eur J Heart Fail 7 (2005) 81-86
8. Luchner A., Hengstenberg C., Lowel H., Riegger G.A., Schunkert H., and Holmer S. Effect of compensated renal dysfunction on approved heart failure markers: direct comparison of brain natriuretic peptide (BNP) and N-terminal pro-BNP. Hypertension 46 (2005) 118-123
9. Redfield M.M., Rodeheffer R.J., Jacobsen S.J., Mahoney D.W., Bailey K.R., and Burnett Jr. J.C. Plasma brain natriuretic peptide concentration: impact of age and gender. J Am Coll Cardiol 40 (2002) 976-982
10. Tsutamoto T., Wada A., Sakai H., et al. Relationship between renal function and plasma brain natriuretic peptide in patients with heart failure. J Am Coll Cardiol 47 (2006) 582-586
11. Anand I.S., Chandrashekhar Y., Ferrari R., Poole-Wilson P.A., and Harris P.C. Pathogenesis of oedema in chronic severe anaemia: studies of body water and sodium, renal function, haemodynamic variables, and plasma hormones. Br Heart J 70 (1993) 357-362
12. Nakagawa O., Ogawa Y., Itoh H., et al. Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy. Evidence for brain natriuretic peptide as an "emergency" cardiac hormone against ventricular overload. J Clin Invest 96 (1995) 1280-1287
13. Willis M.S., Lee E.S., and Grenache D.G. Effect of anemia on plasma concentrations of NT-proBNP. Clin Chim Acta 358 (2005) 175-181
14. Wu A.H., Omland T., Wold K.C., et al. Relationship of B-type natriuretic peptide and anemia in patients with and without heart failure: a substudy from the Breathing Not Properly (BNP) Multinational Study. Am J Hematol 80 (2005) 174-180
15. Felker G.M., Adams Jr. K.F., Gattis W.A., and O'Connor C.M. Anemia as a risk factor and therapeutic target in heart failure. J Am Coll Cardiol 44 (2004) 959-966
16. Hall C. NT-ProBNP: the mechanism behind the marker. J Card Fail 11 (2005) S81-S83
17. Jaarsma T., van der Wal M.H., Hogenhuis J., et al. Design and methodology of the COACH study: a multicenter randomised coordinating study evaluating outcomes of advising and counselling in heart failure. Eur J Heart Fail 6 (2004) 227-233
18. Tjeerdsma G., de Boer R.A., Boomsma F., van den Berg M.P., Pinto Y.M., and van Veldhuisen D.J. Rapid bedside measurement of brain natriuretic peptide in patients with chronic heart failure. Int J Cardiol 86 (2002) 143-149
19. Collinson P.O., Barnes S.C., Gaze D.C., Galasko G., Lahiri A., and Senior R. Analytical performance of the N terminal pro B type natriuretic peptide (NT-proBNP) assay on the Elecsys 1010 and 2010 analysers. Eur J Heart Fail 6 (2004) 365-368
20. van der Meer P., Voors A.A., Lipsic E., van Gilst W.H., and van Veldhuisen D.J. Erythropoietin in cardiovascular diseases. Eur Heart J 25 (2004) 285-291
21. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39 (2002) S1-S266
22. Carlson K.J., Lee D.C., Goroll A.H., Leahy M., and Johnson R.A. An analysis of physicians' reasons for prescribing long-term digitalis therapy in outpatients. J Chronic Dis 38 (1985) 733-739
23. van der Meer P., Lipsic E., Westenbrink B.D., et al. Levels of hematopoiesis inhibitor N-acetyl-seryl-aspartyl-lysyl-proline partially explain the occurrence of anemia in heart failure. Circulation 112 (2005) 1743-1747
24. Silverberg D.S., Wexler D., Blum M., et al. The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations. J Am Coll Cardiol 35 (2000) 1737-1744
25. Wold K.C., Vik-Mo H., and Omland T. Blood haemoglobin is an independent predictor of B-type natriuretic peptide (BNP). Clin Sci (Lond) 109 (2005) 69-74
26. Charles C.J., Espiner E.A., and Richards A.M. Cardiovascular actions of ANF: contributions of renal, neurohumoral, and hemodynamic factors in sheep. Am J Physiol 264 (1993) R533-R538
27. Maack T., Suzuki M., Almeida F.A., et al. Physiological role of silent receptors of atrial natriuretic factor. Science 238 (1987) 675-678
28. Hogenhuis J., Voors A.A., Jaarsma T., Hillege H.L., Hoes A.W., and van Veldhuisen D.J. Low prevalence of B-type natriuretic peptide levels < 100 pg/mL in patients with heart failure at hospital discharge. Am Heart J 151 (2006) 1012e1-1012e5
29. Bruins S., Fokkema M.R., Romer J.W., et al. High intraindividual variation of B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with stable chronic heart failure. Clin Chem 50 (2004) 2052-2058
30. Lainchbury J.G., Troughton R.W., and Frampton C.M. NT-proBNP-guided drug treatment for chronic heart failure: design and methods in the "BATTLESCARRED" trial. Eur J Heart Fail 8 (2006) 532-538